Aris Çakiris
Research Subjects
Aris Çakiris has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Ferda Perçin Paçal
Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey
2 shared publications - Asum Eslem Şahin
İSTANBUL ÜNİVERSİTESİ, FEN FAKÜLTESİ, MOLEKÜLER BİYOLOJİ VE GENETİK BÖLÜMÜ
1 shared publication - Cem Horozoğlu
Haliç Üniversitesi
1 shared publication - Duran Ustek
Department of Genetics, Institute for Experimental Medicine, Istanbul University, Istanbul, Turkey
1 shared publication - Elif Guzel
Department of Histology and Embryology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
1 shared publication - Erdem Tüzün
Istanbul University
1 shared publication
Latest Publications
- Open Access
- 26 October 2026
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 50, 1-11
Thymosin β4 Protects Against Hepatic Ischemia–Reperfusion Injury Through Multi-target Mechanisms
Objective: This study aimed to evaluate the hepatoprotective effects of thymosin β4 (Tβ4) administered at different time points (before ischemia and before reperfusion) in an experimental rat model of hepatic ischemia–reperfusion injury (HIRI). Methods: Thirty-two Sprague–Dawley rats were randomly divided into 4 experimental groups (n = 8 per group): C, IR, Tβ4/IR, and I/Tβ4/R. Ischemia was induced by occlusion of the infrarenal abdominal aorta for 90 minutes, followed by 180 minutes of reperfusion. Oxidative stress (PAB, FRAP, MDA, LOOH, SOD, GSH), inflammatory biomarkers (TNF-α, IL-6, IL-1β, NF-κB), apoptosis- and tissue injury–related biomarkers (caspase-9, MMP-9, hyaluronic acid, nitric oxide), serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities, and histopathological changes were evaluated. Results: Hepatic IR significantly increased oxidative stress, lipid peroxidation, inflammatory cytokines, NF-κB activation, apoptosis-related and tissue injury–related biomarkers, nitric oxide, serum AST/ALT activities, and histopathological injury, while significantly reducing antioxidant capacity (all P < .05). Both Tβ4 treatment protocols attenuated these alterations, with improvements in oxidative stress-related parameters, inflammatory responses, apoptosis-related markers, tissue injury–related biomarkers, liver enzyme levels, and histopathological findings. Both Tβ4/IR and I/Tβ4/R groups showed improvements compared with the IR group. Conclusion: Thymosin β4 demonstrated hepatoprotective effects against HIRI, as evidenced by improvements in oxidative stress, inflammatory, apoptosis-related, biochemical and histopathological parameters. These findings support further investigation of Tβ4 as a potential hepatoprotective agent in experimental HIRI, including evaluation of different administration time points. Cite this article as: Işık M, Şahin G, Bolkent S, et al. Thymosin β4 protects against hepatic ischemia–reperfusion injury through multi-target mechanisms. Cerrahpaşa Med J 2026, 50, 0106, doi: 10.5152/cjm.2026.26106
- 26 October 2026
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 50, 1-11
Open AccessThymosin β4 Protects Against Hepatic Ischemia–Reperfusion Injury Through Multi-target Mechanisms
Objective: This study aimed to evaluate the hepatoprotective effects of thymosin β4 (Tβ4) administered at different time points (before ischemia and before reperfusion) in an experimental rat model of hepatic ischemia–reperfusion injury (HIRI). Methods: Thirty-two Sprague–Dawley rats were randomly divided into 4 experimental groups (n = 8 per group): C, IR, Tβ4/IR, and I/Tβ4/R. Ischemia was induced by occlusion of the infrarenal abdominal aorta for 90 minutes, followed by 180 minutes of reperfusion. Oxidative stress (PAB, FRAP, MDA, LOOH, SOD, GSH), inflammatory biomarkers (TNF-α, IL-6, IL-1β, NF-κB), apoptosis- and tissue injury–related biomarkers (caspase-9, MMP-9, hyaluronic acid, nitric oxide), serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities, and histopathological changes were evaluated. Results: Hepatic IR significantly increased oxidative stress, lipid peroxidation, inflammatory cytokines, NF-κB activation, apoptosis-related and tissue injury–related biomarkers, nitric oxide, serum AST/ALT activities, and histopathological injury, while significantly reducing antioxidant capacity (all P < .05). Both Tβ4 treatment protocols attenuated these alterations, with improvements in oxidative stress-related parameters, inflammatory responses, apoptosis-related markers, tissue injury–related biomarkers, liver enzyme levels, and histopathological findings. Both Tβ4/IR and I/Tβ4/R groups showed improvements compared with the IR group. Conclusion: Thymosin β4 demonstrated hepatoprotective effects against HIRI, as evidenced by improvements in oxidative stress, inflammatory, apoptosis-related, biochemical and histopathological parameters. These findings support further investigation of Tβ4 as a potential hepatoprotective agent in experimental HIRI, including evaluation of different administration time points. Cite this article as: Işık M, Şahin G, Bolkent S, et al. Thymosin β4 protects against hepatic ischemia–reperfusion injury through multi-target mechanisms. Cerrahpaşa Med J 2026, 50, 0106, doi: 10.5152/cjm.2026.26106
- Open Access
- 1 July 2025
- Published by Turkish Astronomical Society in Turkish Journal of Astronomy and Astrophysics
- Vol. 6 (Special : ) , 209-216
Göktaşlarında Yeryüzünün Kirleticileri Konusuna UUİ Uzay Tozu Ölçümü Girişimi ve Yer Laboratuvarı Toz Sayım Örnekleri
Göktaşları Yer atmosferine girdikleri andan itibaren “kirlenmeye” ve taşıdıkları bilgiler eksilmeye başlamaktadır. Düştükleri yerlerde “bulaş” olma durumu da kaçınılmaz olmaktadır. Bulununcaya kadar ve sonrasında kirlilik ve bulaş yine devam etmektedir. Orijinal haline geri dönüşü olamayan kirlilik ve bulaşın modellenebilmesi için yüksek olasılıkla en temiz uzayda UUİ şartlarında ve en kirli de diyebileceğimiz yeryüzü şartlarında mesela toz örnekleri kullanılabilir. Bu amaçla, yeryüzü laboratuvarlarından (İÜ, İÜ-C, İBB, Acme-Kanada ve NASA) elde edilen Çanakkale göktaşı analiz sonuçlarının, UUİ’ndan elde edilenlerden farklı olup olmayacağının belirlenmesi hedeflenmiştir. Bu çalışmada söz konusu amaç doğrultusunda, (1) UUİ uzay tozu ölçümü girişiminde bulunulmuş ve bunun bilgisi burada paylaşılmıştır. (2) İÜ Aziz Sancar Deneysel Tıp Araştırma Enstitüsü laboratuvarında farklı konumlarda 6 lam üzerinde 18 dikdörtgen alanda UUİ görevine uyumlu olarak 7 gün (168) saat süresince toz birikimine (model girdisi-1) ilişkin sonuçlar verilmiştir. Göktaşların inceleneceği araştırma laboratuvarında farklı büyüklüklerde ve şekillerdeki toz yoğunluğu açık alanlarda ortalama 4.1±4.3 toz/m3 ve kapalı ortamlarda 0.7±0.4 toz/m3 (açık alanlar kapalı mekanlara göre yaklaşık 5.7 kat daha kirletici) olduğu belirlenmiştir. Benzer şekilde, tozlanma açık alanlarda ortalama 381.8±317.9 (saatte 2.27) toz ve kapalı mekanlarda ortalama 27.3±17.6 (saatte 0.16) toz (açık alanlar kapalı mekanlara göre yaklaşık 14 kat daha çok kirletici) olduğu belirlenmiştir. Her iki ortalama değerin standart sapmaları (±317.9 ve ±17.6) çok büyük çıkmıştır. Bu durum, seçilen sayım istasyonlarının birbirlerine göre büyük farklılıklarını belirtir ki çevre ve kullanım şartlarına duyarlılığını göstermiştir. Sonuç olarak, göktaşları gibi hassas inceleme ve ölçümlemelerin iyi çevre koşulları altında ve kapalı mekanlarda yapılmasını zorunlu kılmaktadır. Ayrıca, toplanan tozların aynı sürede koruma altına alınarak bulaş (model girdisi-2) olup olmadıklarına ilişkin toz sayımları devam etmektedir. Sonuçlar, uzay tozu ölçümlerine ilişkin devam eden araştırmamızda, üzerinde durduğumuz göktaşların incelenmesinde ve yaşamın genetik araştırma ölçümlerinde Dünya’nın “kirleticilerini” orijinallerinden ayırmaya yönelik “güvenilirlik sınırlarının” belirlenmesinde yararlı olacaktır.
- 1 July 2025
- Published by Turkish Astronomical Society in Turkish Journal of Astronomy and Astrophysics
- Vol. 6 (Special : ) , 209-216
Open AccessGöktaşlarında Yeryüzünün Kirleticileri Konusuna UUİ Uzay Tozu Ölçümü Girişimi ve Yer Laboratuvarı Toz Sayım Örnekleri
Göktaşları Yer atmosferine girdikleri andan itibaren “kirlenmeye” ve taşıdıkları bilgiler eksilmeye başlamaktadır. Düştükleri yerlerde “bulaş” olma durumu da kaçınılmaz olmaktadır. Bulununcaya kadar ve sonrasında kirlilik ve bulaş yine devam etmektedir. Orijinal haline geri dönüşü olamayan kirlilik ve bulaşın modellenebilmesi için yüksek olasılıkla en temiz uzayda UUİ şartlarında ve en kirli de diyebileceğimiz yeryüzü şartlarında mesela toz örnekleri kullanılabilir. Bu amaçla, yeryüzü laboratuvarlarından (İÜ, İÜ-C, İBB, Acme-Kanada ve NASA) elde edilen Çanakkale göktaşı analiz sonuçlarının, UUİ’ndan elde edilenlerden farklı olup olmayacağının belirlenmesi hedeflenmiştir. Bu çalışmada söz konusu amaç doğrultusunda, (1) UUİ uzay tozu ölçümü girişiminde bulunulmuş ve bunun bilgisi burada paylaşılmıştır. (2) İÜ Aziz Sancar Deneysel Tıp Araştırma Enstitüsü laboratuvarında farklı konumlarda 6 lam üzerinde 18 dikdörtgen alanda UUİ görevine uyumlu olarak 7 gün (168) saat süresince toz birikimine (model girdisi-1) ilişkin sonuçlar verilmiştir. Göktaşların inceleneceği araştırma laboratuvarında farklı büyüklüklerde ve şekillerdeki toz yoğunluğu açık alanlarda ortalama 4.1±4.3 toz/m3 ve kapalı ortamlarda 0.7±0.4 toz/m3 (açık alanlar kapalı mekanlara göre yaklaşık 5.7 kat daha kirletici) olduğu belirlenmiştir. Benzer şekilde, tozlanma açık alanlarda ortalama 381.8±317.9 (saatte 2.27) toz ve kapalı mekanlarda ortalama 27.3±17.6 (saatte 0.16) toz (açık alanlar kapalı mekanlara göre yaklaşık 14 kat daha çok kirletici) olduğu belirlenmiştir. Her iki ortalama değerin standart sapmaları (±317.9 ve ±17.6) çok büyük çıkmıştır. Bu durum, seçilen sayım istasyonlarının birbirlerine göre büyük farklılıklarını belirtir ki çevre ve kullanım şartlarına duyarlılığını göstermiştir. Sonuç olarak, göktaşları gibi hassas inceleme ve ölçümlemelerin iyi çevre koşulları altında ve kapalı mekanlarda yapılmasını zorunlu kılmaktadır. Ayrıca, toplanan tozların aynı sürede koruma altına alınarak bulaş (model girdisi-2) olup olmadıklarına ilişkin toz sayımları devam etmektedir. Sonuçlar, uzay tozu ölçümlerine ilişkin devam eden araştırmamızda, üzerinde durduğumuz göktaşların incelenmesinde ve yaşamın genetik araştırma ölçümlerinde Dünya’nın “kirleticilerini” orijinallerinden ayırmaya yönelik “güvenilirlik sınırlarının” belirlenmesinde yararlı olacaktır.
- 12 October 2022
- Published by Central Fisheries Research Institute (SUMAE) in Turkish Journal of Fisheries and Aquatic Sciences
- Vol. 23 (4)
Effects of Different Vegetable Oils on the Fatty Acid Metabolism Based on Whole Body Fatty Acid Balance Method and Gene Expression of Rainbow Trout (Oncorhynchus mykiss)
The objective of conducted research was to analyze the growth performance, fatty acid (FA) metabolism and gene expressions related to polyunsaturated fatty acid (PUFA) metabolism in Oncorhynchus mykiss fed diets containing fish oil (FO), sesame oil (SO), linseed oil (LO) and olive oil (OO). Based on the results of the whole body FA balance method of the study, it was concluded that rainbow trout used n-3 PUFAs as energy and this affected the oxidation of n-6 long-chain polyunsaturated FAs (LC-PUFAs). Gene expression level of the Δ-6 desaturase was the lowest for FO and the highest for SO fed fish (P<0.05). Fish fed with OO had the lowest and fish fed with FO had the highest expression levels of elongase gene (P<0.05). The elongase (ELOVL5) transcription rate was higher in fish fed with FO diet and lower in fish fed with OO diet (P<0.05). In conclusion, this research indicated that the final n-3 PUFA ratio in fish fed with vegetable oil diets can be increased by the addition of 18:3n-3 and the decreased level of total dietary 18:2n-6, the balancing of dietary FAs with a proper content of saturated FA (SFA) and monounsaturated FA (MUFA) is substantial for the best growth.
- 12 October 2022
- Published by Central Fisheries Research Institute (SUMAE) in Turkish Journal of Fisheries and Aquatic Sciences
- Vol. 23 (4)
Effects of Different Vegetable Oils on the Fatty Acid Metabolism Based on Whole Body Fatty Acid Balance Method and Gene Expression of Rainbow Trout (Oncorhynchus mykiss)
The objective of conducted research was to analyze the growth performance, fatty acid (FA) metabolism and gene expressions related to polyunsaturated fatty acid (PUFA) metabolism in Oncorhynchus mykiss fed diets containing fish oil (FO), sesame oil (SO), linseed oil (LO) and olive oil (OO). Based on the results of the whole body FA balance method of the study, it was concluded that rainbow trout used n-3 PUFAs as energy and this affected the oxidation of n-6 long-chain polyunsaturated FAs (LC-PUFAs). Gene expression level of the Δ-6 desaturase was the lowest for FO and the highest for SO fed fish (P<0.05). Fish fed with OO had the lowest and fish fed with FO had the highest expression levels of elongase gene (P<0.05). The elongase (ELOVL5) transcription rate was higher in fish fed with FO diet and lower in fish fed with OO diet (P<0.05). In conclusion, this research indicated that the final n-3 PUFA ratio in fish fed with vegetable oil diets can be increased by the addition of 18:3n-3 and the decreased level of total dietary 18:2n-6, the balancing of dietary FAs with a proper content of saturated FA (SFA) and monounsaturated FA (MUFA) is substantial for the best growth.
- Open Access
- 1 January 2021
- Published by Taylor & Francis in Biotechnology & Biotechnological Equipment
- Vol. 35 (1) , 731-739
Impact of calcitriol and an AKT inhibitor, AT7867, on survival of rat C6 glioma cells
Glioma is the most prevalent and lethal type of primary tumor of central nervous system. The regulatory role of calcitriol, the active form of vitamin D3, has been determined in various cellular processes including cell survival and apoptosis. To study the impact of AKT-pathway inhibition with or without calcitriol combination on glioma cell viability, the effects of AT7867 (AKT-pathway inhibitor) and calcitriol on cell viability and apoptosis were investigated in glioma C6 cell-line. Optimal doses of calcitriol and AT7867 were determined by MTT- and xCELLigence-assays. Both agents (alone/in combination) effectively suppressed the proliferation of C6 cells. While AT7867 inhibited glioma cell viability more effectively than calcitriol, this inhibitory action of AT7867 was not significantly increased by calcitriol combination. The expression levels of vitamin D receptor(VDR)-triggered molecules, AKT-pathway components and apoptosis factors were compared between calcitriol-, AT7867- and calcitriol + AT7867-treated and non-treated cells. CYP24A1 gene was upregulated and DBP, CYP1A1, CYP27B1, EGFRvIII, AKT-pathway (AKT1, MTOR, CREB, PTEN), apoptosis (BAD, CYC-C, CASP3, APAF-1, BCL2) and MMP3 genes were downregulated by calcitriol treatment.AT7867 treatment induced CYP27B1 upregulation, reduced VDR and AKT-pathway (PI3K, MTOR, CREB, PTEN) gene expression levels but showed a relatively less pronounced effect on apoptosis-related gene levels. The combination of calcitriol and AT7867 treatment generated an effect that was similar to that induced by calcitriol alone. Our results demonstrate that calcitriol and AT7867 have differing actions on AKT- and apoptotic-pathways of C6 glioma cell-line. Calcitriol has a lesser viability reducing impact than AT7867 putatively due to its apoptosis inhibiting action. Supplemental data for this article is available online at https://doi.org/10.1080/13102818.2021.1912641 .
- 1 January 2021
- Published by Taylor & Francis in Biotechnology & Biotechnological Equipment
- Vol. 35 (1) , 731-739
Open AccessImpact of calcitriol and an AKT inhibitor, AT7867, on survival of rat C6 glioma cells
Glioma is the most prevalent and lethal type of primary tumor of central nervous system. The regulatory role of calcitriol, the active form of vitamin D3, has been determined in various cellular processes including cell survival and apoptosis. To study the impact of AKT-pathway inhibition with or without calcitriol combination on glioma cell viability, the effects of AT7867 (AKT-pathway inhibitor) and calcitriol on cell viability and apoptosis were investigated in glioma C6 cell-line. Optimal doses of calcitriol and AT7867 were determined by MTT- and xCELLigence-assays. Both agents (alone/in combination) effectively suppressed the proliferation of C6 cells. While AT7867 inhibited glioma cell viability more effectively than calcitriol, this inhibitory action of AT7867 was not significantly increased by calcitriol combination. The expression levels of vitamin D receptor(VDR)-triggered molecules, AKT-pathway components and apoptosis factors were compared between calcitriol-, AT7867- and calcitriol + AT7867-treated and non-treated cells. CYP24A1 gene was upregulated and DBP, CYP1A1, CYP27B1, EGFRvIII, AKT-pathway (AKT1, MTOR, CREB, PTEN), apoptosis (BAD, CYC-C, CASP3, APAF-1, BCL2) and MMP3 genes were downregulated by calcitriol treatment.AT7867 treatment induced CYP27B1 upregulation, reduced VDR and AKT-pathway (PI3K, MTOR, CREB, PTEN) gene expression levels but showed a relatively less pronounced effect on apoptosis-related gene levels. The combination of calcitriol and AT7867 treatment generated an effect that was similar to that induced by calcitriol alone. Our results demonstrate that calcitriol and AT7867 have differing actions on AKT- and apoptotic-pathways of C6 glioma cell-line. Calcitriol has a lesser viability reducing impact than AT7867 putatively due to its apoptosis inhibiting action. Supplemental data for this article is available online at https://doi.org/10.1080/13102818.2021.1912641 .
- Open Access
- 10 January 2019
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 36 (1) , 23-31
Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis
Background: Multiple Myeloma (MM) is plasma cell dyscrasia characterized by transformation of B cells into malignant cells. Although there are data regarding molecular pathology of multiple myeloma, molecularmechanisms of the disease has not been fully explained. Aims: To investigate gene expression profiles in bone marrow myeloma cells via RNA sequencing technology. Study Design: Cell study. Methods: Four untreated MM patients myeloma cells and 4 healthy donors B cells from bone marrow were sorted using FACSAria II. It was occurred two groups as patient pool from myeloma cells and the control pool from B cells. Transcriptome analysis was performed and results were analyzed using bioinformatic tools. Results: Total result of transcriptome data 18.806 transcripts (94.4%) were in pooled MM patients. 992 regions were detected as new exon candidates or altenative splicing regions. In addition, 490 mutations (deletion or insertion) and 1397 SNV were, 415 fusion transcripts, 132 frameshift mutations and 983 fusions which were reported before in NCBI were detected with unknown function were identified in patients. 35.268 transcripts were obtained (71%) (25.355 transcripts were defined previously) in the control pool. This preliminary study, the first 50 genes analyzed with a gene set enchriment analysis program by MSigDB, Enrichr and Panther.Molecular functions, cellular component, pathway and biological process of the genes obtained statistical values by means of bioinformatics tools were presented as supplemental file. Conclusion: EEF1G, ITM2C, FTL, CLPTM1L, and CYBA possible candidate genes were identified in this study which may be associated with myelomagenesis.
- 10 January 2019
- Published by AVES YAYINCILIK A.Ş. in Balkan Medical Journal
- Vol. 36 (1) , 23-31
Open AccessInvestigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis
Background: Multiple Myeloma (MM) is plasma cell dyscrasia characterized by transformation of B cells into malignant cells. Although there are data regarding molecular pathology of multiple myeloma, molecularmechanisms of the disease has not been fully explained. Aims: To investigate gene expression profiles in bone marrow myeloma cells via RNA sequencing technology. Study Design: Cell study. Methods: Four untreated MM patients myeloma cells and 4 healthy donors B cells from bone marrow were sorted using FACSAria II. It was occurred two groups as patient pool from myeloma cells and the control pool from B cells. Transcriptome analysis was performed and results were analyzed using bioinformatic tools. Results: Total result of transcriptome data 18.806 transcripts (94.4%) were in pooled MM patients. 992 regions were detected as new exon candidates or altenative splicing regions. In addition, 490 mutations (deletion or insertion) and 1397 SNV were, 415 fusion transcripts, 132 frameshift mutations and 983 fusions which were reported before in NCBI were detected with unknown function were identified in patients. 35.268 transcripts were obtained (71%) (25.355 transcripts were defined previously) in the control pool. This preliminary study, the first 50 genes analyzed with a gene set enchriment analysis program by MSigDB, Enrichr and Panther.Molecular functions, cellular component, pathway and biological process of the genes obtained statistical values by means of bioinformatics tools were presented as supplemental file. Conclusion: EEF1G, ITM2C, FTL, CLPTM1L, and CYBA possible candidate genes were identified in this study which may be associated with myelomagenesis.